Article Figures & Data
Figures
- FIGURE 1.
Distribution of CgA levels in pheochromocytoma group (A) before surgery and after surgery, in refuted pheochromocytoma group (B), and in control group (C).
- FIGURE 2.
Distribution of CgA levels, of normetanephrine urinary levels (NormetaN), and of metanephrine urinary metabolites (MetaN) in pheochromocytoma group (A; n = 41) and in refuted pheochromocytoma group (B; n = 17).
Tables
Group Cutoff CgA level (ng/mL) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Pheochromocytoma vs. control 100 90.2 99.0 97.3 96.1 110 90.2 100.0 100.0 96.1 Pheochromocytoma vs. refuted pheochromocytoma 100 90.2 92.3 92.5 90.0 110 90.2 94.9 94.7 90.3 PPV = positive predictive value; NPV = negative predictive value.
Group MIBG+/ CgA+ MIBG+/ CgA− MIBG−/ CgA+ MIBG−/ CgA− Pheochromocytoma Before surgery 32 2 3 2 After surgery 0 0 2 11 Refuted pheochromocytoma 0 0 1 34 + = positive; − = negative.
